CTCFL
Basic information
Region (hg38): 20:57495966-57525652
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTCFL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 40 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 41 | 5 | 2 |
Variants in CTCFL
This is a list of pathogenic ClinVar variants found in the CTCFL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-57496289-T-A | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
20-57498563-G-A | not specified | Likely benign (Dec 11, 2023) | ||
20-57498565-G-C | not specified | Uncertain significance (Apr 25, 2023) | ||
20-57498585-T-C | not specified | Uncertain significance (Jun 21, 2023) | ||
20-57498588-C-T | Benign (May 18, 2018) | |||
20-57498603-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
20-57498613-T-G | not specified | Uncertain significance (May 26, 2024) | ||
20-57498618-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
20-57498658-G-T | not specified | Uncertain significance (Mar 21, 2024) | ||
20-57498685-C-G | not specified | Uncertain significance (Jun 29, 2023) | ||
20-57498686-T-A | not specified | Uncertain significance (Oct 27, 2022) | ||
20-57503443-G-A | Likely benign (Feb 01, 2023) | |||
20-57503480-T-C | not specified | Uncertain significance (Mar 29, 2023) | ||
20-57503526-T-C | not specified | Uncertain significance (Mar 06, 2023) | ||
20-57503588-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
20-57508709-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
20-57508717-T-C | Likely benign (Nov 01, 2022) | |||
20-57508728-A-G | not specified | Uncertain significance (Jan 30, 2024) | ||
20-57508764-G-A | not specified | Uncertain significance (May 16, 2024) | ||
20-57512602-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
20-57514630-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
20-57514646-G-C | not specified | Uncertain significance (Mar 19, 2024) | ||
20-57514655-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
20-57514658-C-T | not specified | Likely benign (Oct 02, 2023) | ||
20-57514717-A-G | not specified | Uncertain significance (Mar 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CTCFL | protein_coding | protein_coding | ENST00000423479 | 11 | 29674 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000395 | 1.00 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.733 | 364 | 406 | 0.898 | 0.0000235 | 4626 |
Missense in Polyphen | 82 | 134.11 | 0.61143 | 1438 | ||
Synonymous | -0.892 | 165 | 151 | 1.09 | 0.00000911 | 1275 |
Loss of Function | 3.44 | 12 | 33.5 | 0.358 | 0.00000175 | 409 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000618 | 0.0000615 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Testis-specific DNA binding protein responsible for insulator function, nuclear architecture and transcriptional control, which probably acts by recruiting epigenetic chromatin modifiers. Plays a key role in gene imprinting in male germline, by participating in the establishment of differential methylation at the IGF2/H19 imprinted control region (ICR). Directly binds the unmethylated H19 ICR and recruits the PRMT7 methyltransferase, leading to methylate histone H4 'Arg-3' to form H4R3sme2. This probably leads to recruit de novo DNA methyltransferases at these sites (By similarity). Seems to act as tumor suppressor. In association with DNMT1 and DNMT3B, involved in activation of BAG1 gene expression by binding to its promoter. Required for dimethylation of H3 lysine 4 (H3K4me2) of MYC and BRCA1 promoters. {ECO:0000250, ECO:0000269|PubMed:12011441, ECO:0000269|PubMed:18413740, ECO:0000269|PubMed:18765639}.;
Recessive Scores
- pRec
- 0.0912
Intolerance Scores
- loftool
- 0.600
- rvis_EVS
- 1.18
- rvis_percentile_EVS
- 92.8
Haploinsufficiency Scores
- pHI
- 0.116
- hipred
- N
- hipred_score
- 0.281
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ctcfl
- Phenotype
- cellular phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- regulation of gene expression by genetic imprinting;cell cycle;positive regulation of gene expression;histone methylation;DNA methylation involved in gamete generation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of histone H3-K4 methylation
- Cellular component
- nucleus;cytoplasm
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;protein binding;histone binding;sequence-specific DNA binding;transcription regulatory region DNA binding;metal ion binding